HOME >> MEDICINE >> NEWS
Weizmann Institute Prof. Moshe Oren named winner of NIH MERIT Award

Washington, D.C.--Prof. Moshe Oren, a cancer researcher at the Weizmann Institute of Science in Israel, was named a 2003 winner of the highly selective MERIT (Method to Extend Research in Time) Award. The award is granted by the National Institutes of Health (NIH) for "long-term support to investigators with impressive records of scientific achievement in research areas of special importance or promise."

The NIH hopes the MERIT Award will encourage scientists to "take greater risks, be more adventurous in the lines of inquiry, or take the time to develop new techniques." Less than five percent of NIH investigators are selected to receive the MERIT Award, which provides long-term support for researchers, freeing them from the burden of securing and renewing funding for their work year after year. The award has been presented annually since 1987 to individuals whose "paradigm shifting ideas" and "excellent productivity" make them leaders in their field.

Prof. Oren's research gained the attention of the cancer research world in the early 1980s for his role in cloning p53, the "tumor suppressor gene." Since that time, p53 has been the object of intense scientific scrutiny. It soon became clear that p53 is a part of a complex molecular network, that can suppress -- or fail to suppress -- cancerous growth.

The discovery of p53 and its key role in maintaining healthy cells led to a burgeoning new direction in cancer research. Although it is not the only tumor suppressor gene, mutations in the p53 gene are most common in cancer. In normal cells, p53 sets in motion a complex series of molecular events that can cause cell suicide, or apoptosis -- which, despite its name, is a necessary and healthy mechanism that prevents damaged cells from replicating possibly cancerous mistakes in their DNA. When p53 does not function properly, cancerous cells do not undergo apoptosis, and are able to proliferate in the body. Understanding how p53 works, and
'"/>

Contact: Jeffrey J. Sussman
Jeffrey@acwis.org
212-895-7951
American Committee for the Weizmann Institute of Science
11-Nov-2003


Page: 1 2

Related medicine news :

1. Weizmann Institute receives $8 million grant from Flight Attendant Medical Research Institute
2. Weizmann Women & Science Award to be presented to Dr. Carla J. Shatz; Millennial Lifetime Achievement Award to Dr. Mildred S. Dresselhaus
3. Weizmann Institute scientists develop a potential future treatment for myasthenia gravis
4. Gladstone Institutes rank high in the scientist survey of best places for postdocs
5. Institute of Medicine advisory: Jan. 12 Briefing on Complementary and Alternative Medicine
6. Research by scientists affiliated with the Earth Institute at Columbia University
7. New Jersey Institute of Technology pioneers new way to teach engineers
8. Hopkins Institute for Global Tobacco Control receives elite recognition from PAHO/WHO
9. Six new Roybal Centers for Applied Gerontology established by National Institute on Aging
10. American College of Chest Physicians announces new Critical Care Institute
11. UGA professor receives $3 million grant from National Cancer Institute for breast cancer research

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/25/2016)... California (PRWEB) , ... June 25, 2016 , ... "With ... fit their specific project," said Christina Austin - CEO of Pixel Film Studios. ... customizable and all within Final Cut Pro X . Simply select a ProHand ...
(Date:6/25/2016)... ... June 25, 2016 , ... Conventional wisdom preaches the benefits of moderation, ... the latter, setting the bar too high can result in disappointment, perhaps even self-loathing. ... toward their goal. , Research from PsychTests.com reveals that behind the ...
(Date:6/24/2016)... ... June 24, 2016 , ... ... Scientific Sessions in Dallas that it will receive two significant new grants to ... came as PHA marked its 25th anniversary by recognizing patients, medical professionals and ...
(Date:6/24/2016)... ... June 24, 2016 , ... People across the U.S. ... magazine’s Code Talker Award, an essay contest in which patients and their families pay ... be presented at the 2016 National Society of Genetic Counselors (NSGC) Annual Education Conference ...
(Date:6/24/2016)... ... ... National recruitment firm Slone Partners is pleased to announce the placement of ... President of North American Capital Sales at HTG Molecular . , ... the commercialization of the HTG EdgeSeq system and associated reagents in North America. , ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... 2016 Research and Markets has ... by Type (Organic Chemical (Sugar, Petrochemical, Glycerin), Inorganic Chemical), ... Parenteral) - Global Forecast to 2021" report to ... The global pharmaceutical excipients market is projected to reach ... 6.1% in the forecast period 2016 to 2021. ...
(Date:6/23/2016)... June 23, 2016 Roche (SIX: RO, ROG; ... for its Elecsys BRAHMS PCT (procalcitonin) assay as a ... septic shock. With this clearance, Roche is the first ... integrated solution for sepsis risk assessment and management. ... infection and PCT levels in blood can aid clinicians ...
(Date:6/23/2016)... , June 23, 2016 ... CAPR ), a biotechnology company focused on the ... announced that patient enrollment in its ongoing randomized ... has exceeded 50% of its 24-patient target. Capricor ... the third quarter of 2016, and to report ...
Breaking Medicine Technology:
Cached News: